Clinical Trial Update: A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports a phase 2 study of giredestrant in participants with grade 1 endometrial cancer; the trial is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Giredestrant (giredestrant)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Endometrial Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING